Understanding the Regulatory Landscape for Diagnostic Tests Skip to main content

RU Okay? Understanding the Regulatory Landscape for Diagnostic Tests in the US, UK and EU

RU Okay? Understanding the Regulatory Landscape for Diagnostic Tests in the US, UK and EU

Overview


Join us for an informative discussion on the evolving landscape of In Vitro Diagnostics (IVD) and Lab Developed Tests (LDTs). Our panel of industry leaders will delve into the latest developments from across the US, UK and Europe.

REGISTER

3:00 – 4:00 pm (GMT)
4:00 – 5:00 pm (CET)
10:00 – 11:00 am (EST)

Complimentary Webinar

Agenda


  • The FDA’s proposed rule on LDTs issued in September 2023 – what will this mean for test providers and manufacturers?
  • The landscape for Research Use Only and LDTs in the US, UK and Europe – what are the current exemptions?
  • EU IVDR timelines and extensions – the current transition and understanding when a change is significant
  • Compliance with the new standards – what do you need to know about clinical evidence and timelines to certification?
  • The UK IVD current landscape and the timelines for proposed new regulations – what flexibility is there?

Dig Deeper

Las Vegas, NV and Virtual / Speaking Engagements / February 11 – 13, 2026

AHLA Winter Institute 2026: Advising Providers and AI in Health Care

Dallas, TX / In-person / November 20, 2025

BIO BREAK: Dallas’ Monthly Life Sciences Happy Hour

Boston, MA / In-person / November 13, 2025

Life Sciences Investment Forum 2025

New York, NY / Speaking Engagements / November 5, 2025

NYIPLA One-Day Patent CLE Seminar 2025

Chicago, IL & Virtual / In-person / October 28, 2025

Healthcare Litigation, Compliance, and Investigations Forum 2025